Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin for prevention of PVR-related retinal redetachment
IRCT20191207045645N1Phase 3Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in retinal detachment and Proliferative Vitreoretinopathy (PVR) comparing Atorvastatin with Placebo (2 arms). Started Dec 2019; status: completed.
02
Drugs
atorvastatin
03
Conditions
retinal detachmentProliferative Vitreoretinopathy (PVR)
Beyond the preview
Go deeper on IRCT20191207045645N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20191207045645N1.